Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis- a systematic review

By | July 11th, 2016|

Symptomatic therapy in multiple sclerosis- the role of cannabinoids in treating spasticity

By | July 11th, 2016|

Smoked cannabis for spasticity in multiple sclerosis- a randomized, placebo-controlled trial

By | July 11th, 2016|

Sativex in the Management of Multiple Sclerosis-Related Spasticity- Role of the Corticospinal Modulation

By | July 11th, 2016|

Gottschling cannabinoids with children pain spasticity pain treatment used and palliative medicine 2011 English translation DRAFT 28 Apr 11

By | July 11th, 2016|

Efficacy, safety and tolerability of an orally administered cannabis extract in the treatment of spasticity in patients with multiple sclerosis- a randomized, double-blind, placebo-controlled, crossove

By | July 11th, 2016|

Clinical experiences with cannabinoids in spasticity management in multiple sclerosis

By | July 11th, 2016|

Cannabinoids in the management of spasticity associated with multiple sclerosis

By | July 11th, 2016|

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study)- multicentre randomised placebo-controlled trial

By | July 11th, 2016|

A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis

By | July 11th, 2016|